{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:13:39Z","timestamp":1788970419408,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018722","name":"Stichting Jaap Schouten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anndiagpath.2026.152675","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:38:44Z","timestamp":1782517124000},"page":"152675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6801-3633","authenticated-orcid":false,"given":"Lisa J.","family":"Kroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udia","family":"Cruz Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Hollemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris H.","family":"Bangma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle R.","family":"Downes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc-Nhu Jennifer","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roselyne","family":"Choiniere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus H.","family":"van der Kwast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"van Klaveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152675_bb0005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152675_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.euros.2022.04.011","article-title":"Risk estimation of metastatic recurrence after prostatectomy: a model using preoperative magnetic resonance imaging and targeted biopsy","volume":"41","author":"Bommelaere","year":"2022","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152675_bb0015","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.eururo.2015.10.029","article-title":"Clinical utility of quantitative Gleason Grading in prostate biopsies and prostatectomy specimens","volume":"69","author":"Sauter","year":"2016","journal-title":"Eur Urol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2026.152675_bb0020","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2005.03.018","article-title":"The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy","volume":"23","author":"Cheng","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152675_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pathol.2021.11.004","article-title":"Percentage grade 4 tumour predicts outcome for prostate adenocarcinoma in needle biopsies from patients with advanced disease: 10-year data from the TROG 03.04 RADAR trial","volume":"54","author":"Delahunt","year":"2022","journal-title":"Pathology"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152675_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.eururo.2024.02.017","article-title":"How to report the minor component of a high-grade pattern in radical prostatectomy specimens: time to abandon the \u201ctertiary\u201d terminology?","volume":"86","author":"Cimadamore","year":"2024","journal-title":"Eur Urol"},{"issue":"18","key":"10.1016\/j.anndiagpath.2026.152675_bb0035","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1200\/JCO.2015.65.7759","article-title":"Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement","volume":"34","author":"Chen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152675_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152675_bb0045","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2023.03.014","article-title":"Impact of epithelial histological types, subtypes, and growth patterns on oncological outcomes for patients with nonmetastatic prostate cancer treated with curative intent: a systematic review","volume":"84","author":"Marra","year":"2023","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152675_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152675_bb0055","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152675_bb0060","series-title":"Edn. Presented at the EAU Annual Congress Madrid","author":"EAU Guidelines","year":"2025"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152675_bb0065","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.eururo.2017.01.015","article-title":"Integrating tertiary Gleason 5 patterns into quantitative Gleason grading in prostate biopsies and prostatectomy specimens","volume":"73","author":"Sauter","year":"2018","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152675_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2019.07.051","article-title":"Improved prostate cancer biopsy grading by incorporation of invasive cribriform and intraductal carcinoma in the 2014 grade groups","volume":"77","author":"van Leenders","year":"2020","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152675_bb0075","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00428-022-03301-y","article-title":"Alternative prostate cancer grading systems incorporating percent pattern 4\/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomy","volume":"480","author":"Seyrek","year":"2022","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152675_bb0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PAS.0000000000001384","article-title":"Prostate carcinoma grade and length but not cribriform architecture at positive surgical margins are predictive for biochemical recurrence after radical prostatectomy","volume":"44","author":"Hollemans","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152675_bb0085","series-title":"Ajcc cancer staging manual","author":"American Joint Committee on Cancer (AJCC)","year":"2017"},{"issue":"446","key":"10.1016\/j.anndiagpath.2026.152675_bb0090","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"30","key":"10.1016\/j.anndiagpath.2026.152675_bb0095","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1002\/sim.5958","article-title":"Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks","volume":"32","author":"Blanche","year":"2013","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152675_bb0100","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.anndiagpath.2026.152675_bb0105","series-title":"Modeling survival data: extending the cox model","author":"Therneau","year":"2000"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152675_bb0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.juro.2016.05.105","article-title":"Outcome of Gleason 3 + 5 = 8 prostate Cancer diagnosed on needle biopsy: prognostic comparison with Gleason 4 + 4 = 8","volume":"196","author":"Harding-Jackson","year":"2016","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152675_bb0115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152675_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-024-00802-6","article-title":"Does prostate cancer without cribriform pattern have metastatic potential?","author":"Kroon","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152675_bb0125","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/his.14901","article-title":"Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer","volume":"82","author":"Oufattole","year":"2023","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152675_bb0130","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0000000000000691","article-title":"Prognostic significance of percentage and architectural types of contemporary Gleason pattern 4 prostate cancer in radical prostatectomy","volume":"40","author":"Choy","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152675_bb0135","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.eururo.2006.07.051","article-title":"Should we replace the Gleason score with the amount of high-grade prostate cancer?","volume":"51","author":"Vis","year":"2007","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152675_bb0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.euf.2023.08.010","article-title":"Limitations of prostate biopsy in detection of cribriform and intraductal prostate cancer","volume":"10","author":"Bernardino","year":"2024","journal-title":"Eur Urol Focus"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152675_bb0145","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000001728","article-title":"ISUP consensus definition of cribriform pattern prostate cancer","volume":"45","author":"van der Kwast","year":"2021","journal-title":"Am J Surg Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913426000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:33:01Z","timestamp":1788967981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913426000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"alternative-id":["S1092913426000717"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152675","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152675"}}